Growth Metrics

Akebia Therapeutics (AKBA) Amortizatization of Intangibles: 2016-2024

Historic Amortizatization of Intangibles for Akebia Therapeutics (AKBA) over the last 9 years, with Dec 2024 value amounting to $9.0 million.

  • Akebia Therapeutics' Amortizatization of Intangibles changed negligibly% to $9.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was $36.0 million, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $36.0 million for FY2024, which is negligibly% changed negligibly from last year.
  • Akebia Therapeutics' Amortizatization of Intangibles amounted to $9.0 million in Q4 2024, which was up 0.11% from $9.0 million recorded in Q3 2024.
  • Akebia Therapeutics' Amortizatization of Intangibles' 5-year high stood at $9.1 million during Q1 2020, with a 5-year trough of $6.1 million in Q3 2020.
  • Moreover, its 3-year median value for Amortizatization of Intangibles was $9.0 million (2022), whereas its average is $9.0 million.
  • Per our database at Business Quant, Akebia Therapeutics' Amortizatization of Intangibles crashed by 32.97% in 2020 and then soared by 47.54% in 2021.
  • Akebia Therapeutics' Amortizatization of Intangibles (Quarterly) stood at $8.3 million in 2020, then climbed by 8.44% to $9.0 million in 2021, then remained steady at $9.0 million in 2022, then declined by 0.01% to $9.0 million in 2023, then remained steady at $9.0 million in 2024.
  • Its Amortizatization of Intangibles was $9.0 million in Q4 2024, compared to $9.0 million in Q3 2024 and $9.0 million in Q2 2024.